SEC Comment Letter 0000000000-23-010332 to Alpha Tau Medical Ltd. (DRTS)
Alpha Tau Medical Ltd.
Date: Sept. 19, 2023 · CIK: 0001871321 · Accession: 0000000000-23-010332
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-274457
Letter
United States securities and exchange commission logo September 19, 2023 Uzi Sofer Chief Executive Officer Alpha Tau Medical Ltd. Kiryat HaMada St. 5 Jerusalem, Israel 9777605 Re:Alpha Tau Medical Ltd. Registration Statement on Form F-3 Filed September 11, 2023 File No. 333-274457 Dear Uzi Sofer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Benjamin Richie at 202-551-7857 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Michael J. Rosenberg
Show Raw Text
United States securities and exchange commission logo
September 19, 2023
Uzi Sofer
Chief Executive Officer
Alpha Tau Medical Ltd.
Kiryat HaMada St. 5
Jerusalem, Israel 9777605
Re:Alpha Tau Medical Ltd.
Registration Statement on Form F-3
Filed September 11, 2023
File No. 333-274457
Dear Uzi Sofer:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Michael J. Rosenberg